Skip to main content

Table 4 Experiences with counseling and services, by method received

From: What are the prospects for the hormonal IUD in the public sector? A mixed-method study of the user population in Zambia

 

Hormonal IUD

n = 153

Copper IUD

n = 168

Implant

n = 286

Injectable

n = 103

Told by provider about other methods (%)

143 (93.5)

162 (96.4)

256 (89.5)

95 (92.2)

Told about bleeding changes and/or side effects (%)

146 (95.4)

152 (90.5)

253 (88.5)

85 (82.5)

Side effects mentioned by provider (%) a

    

 Headaches

24 (16.4)

32 (21.1)

75 (29.6)

33 (38.8)

 Nausea/vomiting

9 (6.2)

16 (10.5)

49 (19.4)

23 (27.1)

 Weight gain

10 (6.8)

10 (6.6)

58 (22.9)

23 (27.1)

 Other

42 (28.8)

62 (40.8)

81 (32.0)

23 (27.1)

 Any type of side effect

54 (37.0)

66 (43.4)

124 (49.0)

44 (51.8)

Bleeding changes mentioned by provider (%)a

    

 Lighter or shorter bleeding

128 (87.7)

113 (74.3)

136 (53.8)

48 (56.5)

 No bleeding

63 (43.2)

53 (34.9)

137 (54.2)

54 (63.5)

 Heavier or longer bleeding

34 (23.3)

45 (29.6)

147 (58.1)

56 (65.9)

 Bleeding disturbances

65 (44.5)

66 (43.4)

168 (66.4)

51 (60.0)

 Less pain during period

36 (24.7)

38 (25.0)

19 (7.5)

7 (8.2)

 Any type of bleeding change

146 (100.0)

148 (97.4)

250 (98.8)

84 (98.8)

Correctly reported method duration (%)b

146 (95.4)

158 (94.0)

260 (92.5)

101 (98.1)

Told by provider at insertion that method can be removed at any time they want (%)

149 (97.4)

165 (98.2)

259 (91.2)

N/A

Told at insertion where removal can be obtained (%)

    

 Insertion place only

61 (39.9)

31 (18.5)

84 (29.6)

N/A

 Place other than insertion place only

2 (1.3)

6 (3.6)

13 (4.6)

N/A

 Insertion place and another place

88 (57.5)

126 (75.0)

165 (58.1)

N/A

 Not told about any place, don’t know

2 (1.3)

5 (3.0)

22 (7.8)

N/A

Felt privacy sufficient when received method (%)

151 (98.7)

165 (98.2)

284 (99.3)

89 (86.4)

Experienced pain/discomfort when received method (%)c

31 (20.3)

28 (16.7)

43 (15.0)

9 (8.7)

  1. aAmong women counseled on bleeding changes and/or side effects. Multiple responses possible
  2. bBased on the duration participants recalled being told by providers when receiving the method. For implants, correct duration was determined based on implant type as informed by participant reports of the number of rods in their implants. Those who did not know their implant type (n = 5) were excluded
  3. CResponse options included temporary pain, discomfort/pain that lasted a few days, continuing pains, cramping, infection/swelling, scarring or other